COFPRIS was evaluated by a group of experts from PAHO/WHO (Pan American Health Organization/World Health Organization) and the national regulatory authorities of Brazil, Chile, Costa Rica, Cuba who verified the commission’s performance in product registration, licensing of producers and establishments, inspection of good manufacturing practices, authorization and monitoring of clinical trial, and activities for quality control and batch release.